Eris Lifesciences Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
29.28 | 59.58 | -50.85% | 24.44 | +19.82% |
| P/S |
|
5.76 | 9.34 | -38.27% |
|
|
| P/BV |
|
3.56 | 6.65 | -46.42% |
|
|
| P/FCF |
|
25.33 | -112.82 | -122.45% |
|
|
| Ev/Ebitda |
|
20.28 | 141.59 | -85.68% |
|
|
| Ev/S |
|
7.11 | 9.61 | -25.97% |
|
|
| Ev/FCF |
|
39.7 | -86.46 | -145.92% |
|
|
| E/P |
|
0.0434 | 0.1121 | -61.29% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
35.08 | 5.7 | 515.62% | 35.62 | -1.51% |
| ROE |
|
16.39 | 10.72 | 52.86% |
|
|
| ROA |
|
7.32 | 7.64 | -4.22% |
|
|
| ROIC |
|
0 | 15.91 | -100% |
|
|
| ROS |
|
19.68 | -4.5 | -537.3% |
|
|
| ROCE |
|
16.02 | 13.31 | 20.34% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
3/10
|
3.98 | 121.74 | -96.73% | 1.95 | +104.31% |
| Nеt Debt/Ebitda |
|
3.85 | 121.47 | -96.83% |
|
|
| Debt/Ratio |
|
0.3946 | 0.145 | 172.03% |
|
|
| Debt/Equity |
|
7.37 | 2.02 | 264.84% |
|
|
| Debt/Net Income |
|
7.1 | 5.06 | 40.15% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
1.48/10
|
0.5945 | 9.47 | -93.72% | 1.18 | -49.67% |
| Number of years of dividend growth |
|
0 | 0.878 | -100% | ||
| DSI |
|
0.9167 | 0.8391 | 9.24% |
|
|
| Average dividend growth |
|
16.08 | 0.8297 | 1837.8% |
|
|
| Average percentage for 5 years |
|
1.18 | 15.05 | -92.15% |
|
|
| Average percentage for payments |
|
39.28 | 24.67 | 59.21% |
|
|
| Difference from average difference in sector |
|
-8.87 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
9/10
|
88.18 | 381.34 | -76.88% | ||
| Growth impulse Ebitda in 5 years |
|
84.4 | 396.06 | -78.69% | ||
| Growth impulse Net Income in 5 years |
|
32.2 | 642.47 | -94.99% | ||
| Growth impulse FCF in 5 years |
|
197.8 | 791.1 | -75% | ||
| Growth impulse EPS in 5 years |
|
33.58 | 176.76 | -81% |
IP Score
5.09/10
